subject area of
- Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia Journal Articles
- Blood lipid profiles in children with acute lymphoblastic leukemia Journal Articles
- Central venous line–related thrombosis in children: association with central venous line location and insertion technique Journal Articles
- Cerebral sinus venous thrombosis during childhood acute lymphoblastic leukemia therapy: Risk factors and management Journal Articles
- Effect of disease and chemotherapy on hemostasis in children with acute lymphoid leukemia. Journal Articles
- Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemia Journal Articles
- Efficacy and Toxicity of Pegaspargase and Calaspargase Pegol in Childhood Acute Lymphoblastic Leukemia: Results of DFCI 11-001 Journal Articles
- Evaluation for inherited and acquired prothrombotic defects predisposing to symptomatic thromboembolism in children with acute lymphoblastic leukemia: a protocol for a prospective, observational, cohort study Journal Articles
- Favorable Outcome for Adolescents With Acute Lymphoblastic Leukemia Treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols Conferences
- Hemophagocytic Lymphohistiocytosis Onset During Induction Therapy for Precursor B-cell Acute Lymphoblastic Leukemia Journal Articles
- Impairment of health‐related quality of life for children with acute lymphoblastic leukemia over the first year of therapy: A report from the DFCI ALL Consortium Journal Articles
- Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01 Journal Articles
- Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia Journal Articles
- Intravenous pegylated asparaginase versus intramuscular native Escherichia coli l-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial Journal Articles
- Long-term outcome of a pediatric-inspired regimen used for adults aged 18–50 years with newly diagnosed acute lymphoblastic leukemia Journal Articles
- Management of Children with Acute Lymphoblastic Leukemia by the Dana-Farber Cancer Institute Protocols Journal Articles
- Management of Ontario children with acute lymphoblastic leukemia by the Dana-Farber Cancer Institute protocols. Journal Articles
- Osteopenia in children with acute lymphoblastic leukemia: A pilot study of amelioration with pamidronate Journal Articles
- Postinduction Dexamethasone and Individualized Dosing of Escherichia Coli L-Asparaginase Each Improve Outcome of Children and Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia: Results From a Randomized Study—Dana-Farber Cancer Institute ALL Consortium Protocol 00-01 Journal Articles
- Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia Journal Articles
- The international scandal of defective asparaginase: A blight on children with cancer Journal Articles
- Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana‐Farber Cancer Institute protocols: effect of age and risk stratification of disease Journal Articles
- Thrombosis in Children with Acute Lymphoblastic Leukemia Treated at a Tertiary Care Center in Lebanon: Revisiting the Role of Predictive Models Journal Articles